Post-marketing safety surveillance of the BBIBP-CorV (Sinopharm) COVID-19 vaccine in Peruvian healthcare workers: A retrospective analysis of a Pharmacovigilance Center

Key Points

• Adverse events reported included fatigue and nausea among healthcare workers, indicating potential vaccine side effects.
• Data extracted from the Pharmacovigilance Center revealed significant safety signals from BBIBP-CorV vaccinations.
• Retrospective analysis of vaccine administration records identified safety outcomes over a specified observation period.
• Findings highlight the need for ongoing monitoring of COVID-19 vaccine safety in diverse populations.